Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-HLA Antibody”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableUnknownNCT06021925
What this trial is testing

Obstetrical History and Anti-HLA Antibodies Level

Who this might be right for
Blood DonorsAnti-HLA Antibody
Assistance Publique - Hôpitaux de Paris 6,000
Not applicableStudy completedNCT03798860
What this trial is testing

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

Who this might be right for
Lung TransplantationDonor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
Hannover Medical School 340
Post-approval studies (Phase 4)Study completedNCT03794492
What this trial is testing

Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 169
Not applicableActive Not RecruitingNCT04277377
What this trial is testing

Nanoparticle for DSA Removal

Who this might be right for
Kidney FailurePresence of Donor Specific Antibodies
University of Zurich 100
Early research (Phase 1)Looking for participantsNCT07584954
What this trial is testing

Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors

Who this might be right for
Solid Tumor CancerSolid Tumor Cancer Treatment With Immunotherapy
Jun Zhou 90
Large-scale testing (Phase 3)Study completedNCT04302805
What this trial is testing

RATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)

Who this might be right for
Kidney Transplantation
Institute for Clinical and Experimental Medicine 17
Not applicableUnknownNCT02556879
What this trial is testing

Immunization Anti HLA in the Liver Transplant Recipients (DSATH)

Who this might be right for
Liver TransplantationGraft Failure
Assistance Publique - Hôpitaux de Paris 100
Not applicableStudy completedNCT07474857
What this trial is testing

Anti-HLA Antibodies After Bone Regeneration Surgery

Who this might be right for
Alveolar Bone LossMaxillary Sinus Bone Loss
Medical Innovation Center Wroclaw 20
Testing effectiveness (Phase 2)Study completedNCT00446251
What this trial is testing

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 14
Testing effectiveness (Phase 2)Study completedNCT00002554
What this trial is testing

Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Not applicableStudy completedNCT06395220
What this trial is testing

Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Haematological Malignancy
Peking University People's Hospital 314
Not applicableStudy completedNCT07200583
What this trial is testing

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Who this might be right for
Hematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more
Ting YANG 50
Not applicableUnknownNCT03815864
What this trial is testing

Antibodies and Liver Retransplantation

Who this might be right for
Liver Transplant FailureAntibody-mediated Rejection
London Health Sciences Centre 200
Testing effectiveness (Phase 2)Study completedNCT00027560
What this trial is testing

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 51
Not applicableWithdrawnNCT00460824
What this trial is testing

A Retrospective Review - Anti-HLA Antibodies

Who this might be right for
Congenital Disorders
Emory University
Early research (Phase 1)Ended earlyNCT00589316
What this trial is testing

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+7 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00090194
What this trial is testing

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Who this might be right for
Kidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableStudy completedNCT05399693
What this trial is testing

Platelet Transfusion Refractoriness

Who this might be right for
Platelet Transfusion Refractoriness
Institut de cancérologie Strasbourg Europe 50
Testing effectiveness (Phase 2)Study completedNCT03380377
What this trial is testing

Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Who this might be right for
Antibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more
Stanley Jordan, MD 10
Next Page
26